Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $152B |
| FY2017, ended Dec 31, 2017 | $213B |
| FY2018, ended Dec 31, 2018 | $239B |
| FY2019, ended Dec 31, 2019 | $279B |
| FY2020, ended Dec 31, 2020 | $332B |
| FY2021, ended Dec 31, 2021 | $472B |
| FY2022, ended Dec 31, 2022 | $495B |
| FY2023, ended Dec 31, 2023 | $485B |
| FY2024, ended Dec 31, 2024 | $463B |
| FY2025, ended Dec 31, 2025 | $300B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $373B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $185B |
| FY2017, ended Dec 31, 2017 | $201B |
| FY2018, ended Dec 31, 2018 | $226B |
| FY2019, ended Dec 31, 2019 | $242B |
| FY2020, ended Dec 31, 2020 | $257B |
| FY2021, ended Dec 31, 2021 | $288B |
| FY2022, ended Dec 31, 2022 | $324B |
| FY2023, ended Dec 31, 2023 | $372B |
| FY2024, ended Dec 31, 2024 | $400B |
| FY2025, ended Dec 31, 2025 | $448B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $450B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $7.02B | $8.09B |
| FY2017, ended Dec 31, 2017 | $10.6B | $11.6B |
| FY2018, ended Dec 31, 2018 | $12.0B | $13.7B |
| FY2019, ended Dec 31, 2019 | $13.8B | $16.4B |
| FY2020, ended Dec 31, 2020 | $15.4B | $20.1B |
| FY2021, ended Dec 31, 2021 | $17.3B | $19.9B |
| FY2022, ended Dec 31, 2022 | $20.1B | $23.4B |
| FY2023, ended Dec 31, 2023 | $22.4B | $25.7B |
| FY2024, ended Dec 31, 2024 | $14.4B | $20.7B |
| FY2025, ended Dec 31, 2025 | $12.1B | $16.1B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $14.1B | $23.6B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $10.4B |
| FY2017, ended Dec 31, 2017 | $12.0B |
| FY2018, ended Dec 31, 2018 | $10.9B |
| FY2019, ended Dec 31, 2019 | $11.0B |
| FY2020, ended Dec 31, 2020 | $16.9B |
| FY2021, ended Dec 31, 2021 | $21.4B |
| FY2022, ended Dec 31, 2022 | $23.4B |
| FY2023, ended Dec 31, 2023 | $25.4B |
| FY2024, ended Dec 31, 2024 | $25.3B |
| FY2025, ended Dec 31, 2025 | $24.4B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $28.6B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $33.0B |
| FY2017, ended Dec 31, 2017 | $31.7B |
| FY2018, ended Dec 31, 2018 | $36.6B |
| FY2019, ended Dec 31, 2019 | $40.7B |
| FY2020, ended Dec 31, 2020 | $43.5B |
| FY2021, ended Dec 31, 2021 | $46.0B |
| FY2022, ended Dec 31, 2022 | $57.6B |
| FY2023, ended Dec 31, 2023 | $62.5B |
| FY2024, ended Dec 31, 2024 | $76.9B |
| FY2025, ended Dec 31, 2025 | $78.4B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $73.3B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 5.6% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 951M |
| FY2017, ended Dec 31, 2017 | 968M |
| FY2018, ended Dec 31, 2018 | 960M |
| FY2019, ended Dec 31, 2019 | 949M |
| FY2020, ended Dec 31, 2020 | 945M |
| FY2021, ended Dec 31, 2021 | 941M |
| FY2022, ended Dec 31, 2022 | 933M |
| FY2023, ended Dec 31, 2023 | 922M |
| FY2024, ended Dec 31, 2024 | 915M |
| FY2025, ended Dec 31, 2025 | 908M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 898M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash |
|---|---|---|---|
| FY2016, ended Dec 31, 2016 | $1.28B | $485M | $429M |
| FY2017, ended Dec 31, 2017 | $1.50B | $597M | $688M |
| FY2018, ended Dec 31, 2018 | $4.50B | $638M | $838M |
| FY2019, ended Dec 31, 2019 | $5.50B | $697M | $1.04B |
| FY2020, ended Dec 31, 2020 | $4.25B | $679M | $1.44B |
| FY2021, ended Dec 31, 2021 | $5.00B | $800M | $1.35B |
| FY2022, ended Dec 31, 2022 | $7.00B | $925M | $1.25B |
| FY2023, ended Dec 31, 2023 | $8.00B | $1.06B | $1.35B |
| FY2024, ended Dec 31, 2024 | $9.00B | $1.02B | $1.85B |
| FY2025, ended Dec 31, 2025 | $5.54B | $971M | $827M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $1.65B | $1.02B | $605M |
Valuation
At current price- Market Cap
- $368B
- P/E
- 26.1×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 0.8×
- Price / Book
- 3.5×
- EV / EBITDA
- 15.9×
Growth
Trailing 12 months- Revenue (TTM)
- $450B
- Revenue Growth YoY
- 6.5%
- Revenue CAGR 3Y
- 11.4%
- Revenue CAGR 5Y
- 11.7%
- EPS Growth YoY
- −32.6%
- Net Income Growth YoY
- −33.7%
Profitability
Trailing 12 months- Gross Margin
- 88.6%
- Operating Margin
- 4.8%
- Net Margin
- 3.1%
- FCF Margin
- 5.2%
- Return on Equity
- 13.8%
Earnings
Trailing 12 months- Net Income
- $14.1B
- EPS (diluted)
- $15.56
- EBITDA
- $26.0B
- Operating Income
- $21.7B
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $28.6B
- Total Debt
- $73.3B
- Net Debt
- $44.7B
- Total Assets
- $310B
- Total Liabilities
- $204B
- Shareholders' Equity
- $105B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $27.0B
- Capital Expenditure
- $3.40B
- Free Cash Flow
- $23.6B
Dividends and risk
Last 12 months- Dividend Yield
- 2.2%
- Dividend / Share
- $9.06
- Beta (5Y)
- 0.61
Every ratio is calculated from the company’s reported figures.